India invests millions to develop SMEs for CRO market
This article was originally published in Clinica
Executive Summary
India is investing Rs5bn ($117m) in an initiative to boost the standard of small and medium contract research organisations (CROs). The move is part of efforts to gear SMEs up for the increasing international interest to conduct research in India, as well as to tap the local clinical trials market, estimated to be worth $600m by 2010.